Skip to main content
OpenTrials
Completed

NCT Number: NCT00843570

Natural Versus HRT Cycles in Frozen Embryo Replacement Treatment

Frozen Embryo Replacement (FER)is a fertility treatment by which stored embryos from a fresh IVF treatment cycle are thawed and transferred into the uterus. Frozen embryos can be replaced either in the middle of a natural menstrual cycle (Natural FER) or in a cycle where the woman takes drugs to suppress her own hormones, and then takes Hormone Replacement Therapy (HRT) to prepare her uterus for the transfer of embryos(HRT - FER).

Both are widely used methods of fertility treatment. However, to date no well designed studies have been reported in which the two methods have been compared. This study aims to compare the two treatments in order to establish the best treatment protocol.

The study design is a single centre open randomized controlled trial funded by the Oxford Fertility Unit.

100 women who are considering FER treatment at the Oxford Fertility Unit and are eligible for the study will be recruited.

After giving their written consent they will be randomised to one of 2 groups: Natural FER and HRT FER.

Patients in both groups will be asked to attend one initial visit, which is additional to patients not taking part in the study.

Subsequent visits will depend on the treatment group but will not be additional for study participants. All visits requiring ultrasound will involve recording 3-D measurements, which increases the length of each visit by approximately 10 minutes. A patient satisfaction questionnaire would be completed at the end of the cycle.

A urinary pregnancy test is performed at home 2 weeks following the embryo transfer visit. If this is positive then further visits to the unit are arranged to confirm the clinical pregnancy.

Inclusion in the study would not increase the length of time of either treatment cycle. Follow up would extend to obtaining pregnancy outcome information.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–40 year

Sex eligibility

Female

Study type

Interventional

Phase

Phase 4

Primary location

Nuffield Department of Obstetrics and Gynaecology, University of Oxford, Oxford, Oxfordshire, United Kingdom

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Women attending Oxford Fertility Unit planning a frozen embryo replacement cycle.
  • Willing and able to give informed consent for participation in the study.
  • Age at original fresh IVF cycle < 40 years old.
  • At least 3 embryos frozen in storage
  • First or second FER cycle
  • Regular ovulatory menstrual cycles, confirmed by luteal progesterone levels >16nmol/L and with cycle length < 35 days.

Exclusion criteria

  • Women with irregular cycles (outlined above), including amenorrhoea or oligomenorrhoea.
  • Co-existing medical illness including renal, cardiac and liver disease
  • Women for whom the study medication(s) are contraindicated or who have known allergic reactions to study medication(s)
  • Women who have already taken part in this trial (i.e. cannot have more than one treatment cycle as a participant in this trial)

Treatment and study plan

Nafarelin acetate, Oestradiol Valerate, Progesterone

Drug

Nafarelin acetate, Nasal spray, 400 mcg b.d., 4 weeks Oestradiol Valerate, tablet, 2mg o.d day 1-5, 2mg b.d. day 6-9, 2mg t.d.s day 10-13 (step-up protocol), 2mg q.d.s (if pregnancy confirmed, 4-10 weeks Progesterone, pessary, 200mg b.d. and t.d.s. (if pregnancy confirmed), 2-10 weeks

Other names: Synarel,Progynova,Cyclogest

Primary outcomes

  1. The live birth rate in each group

    Time frame: 22 - 40 weeks following embryo transfer

Secondary outcomes

  1. Clinical pregnancy rates (CPR)

    Time frame: 4 weeks after embryo transfer (at 6/40 pregnancy)

  2. Implantation rate (defined as the number gestational sacs visible on ultrasound divided by the number of embryos replaced and expressed in percentage)

    Time frame: 4 weeks following embryo transfer (6/40 pregnancy)

  3. 3D endometrial volume and blood flow indices

    Time frame: various from day 1 to embryo transfer

  4. Patient satisfaction with treatment

    Time frame: 4-10 weeks (at embryo transfer)

Sponsors and collaborators

Lead sponsor

University of Oxford

Other

Collaborators

  • Oxford Fertility Unit

Registry information

Official study title

A Randomised Controlled Trial of Natural Versus Hormone Replacement Therapy Cycles in Frozen Embryo Replacement IVF: a Pilot Study

Important dates

Study start
2009
Primary completion
2013
Study completion
2013
First posted
Feb 13, 2009
Registry last updated
Jul 25, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.